TRAF5 and TRAF3IP2 gene polymorphisms are associated with Behçet's disease and Vogt-Koyanagi-Harada syndrome: a case-control study
- PMID: 24416204
- PMCID: PMC3885545
- DOI: 10.1371/journal.pone.0084214
TRAF5 and TRAF3IP2 gene polymorphisms are associated with Behçet's disease and Vogt-Koyanagi-Harada syndrome: a case-control study
Abstract
Background: TRAF5 and TRAF3IP2 have been reported to be associated with several autoimmune diseases. Behçet's disease (BD) and Vogt-Koyanagi-Harada (VKH) syndrome are two autoimmune uveitis entities whereby both genetic and environmental factors are thought to be involved.
Objective: The role of TRAF5 and TRAF3IP2 in BD and VKH has not yet been reported and was therefore the subject of this study.
Methods: The study included 789 BD patients, 940 VKH patients and 1601 healthy unrelated individuals. Genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) or TaqMan® SNP Genotyping Assay. Real-Time PCR was used to detect mRNA expression from PBMCs obtained from healthy controls with (n = 22) or without (n = 79) stimulation. Levels of TNF-α, IL-6 and IL-8 in culture supernatants were measured by ELISA (n = 22).
Results: Three SNPs (rs6540679, rs12569232, rs10863888) of TRAF5 and rs13210247 of TRAF3IP2 were significantly associated with Behçet's disease and VKH syndrome (corrected P values ranging from 9.45×10(-12) to 0.027). TRAF3IP2 rs33980500 and rs13190932 were not polymorphic in Han Chinese. Following stimulation by lipopolysaccharide (LPS), carriers of the GG genotype of rs6540679/TRAF5 had a higher TRAF5 mRNA expression (p = 0.004) and an increased TNF-α (p = 0.0052) and IL-6 (p = 0.0014) level compared with AA and AG genotype carriers.
Conclusion: This study provides evidence that TRAF5 and TRAF3IP2 genes are involved in the development of BD and VKH syndrome. Functional research suggested that TRAF5 gene polymorphisms may regulate TRAF5 expression and downstream inflammatory cytokines such as TNF-α and IL-6.
Conflict of interest statement
Figures



Similar articles
-
A variant of CLEC16A gene confers protection for Vogt-Koyanagi-Harada syndrome but not for Behcet's disease in a Chinese Han population.Exp Eye Res. 2015 Mar;132:225-30. doi: 10.1016/j.exer.2015.01.004. Epub 2015 Jan 7. Exp Eye Res. 2015. PMID: 25576669
-
Association of TLR2 gene polymorphisms with ocular Behcet's disease in a Chinese Han population.Invest Ophthalmol Vis Sci. 2013 Dec 30;54(13):8384-92. doi: 10.1167/iovs.13-12878. Invest Ophthalmol Vis Sci. 2013. PMID: 24255044
-
Interleukin-10 gene polymorphisms are associated with Behcet's disease but not with Vogt-Koyanagi-Harada syndrome in the Chinese Han population.Mol Vis. 2015 May 22;21:589-603. eCollection 2015. Mol Vis. 2015. PMID: 26015771 Free PMC article.
-
Uveitis genetics.Exp Eye Res. 2020 Jan;190:107853. doi: 10.1016/j.exer.2019.107853. Epub 2019 Oct 25. Exp Eye Res. 2020. PMID: 31669406 Review.
-
The association between vitamin D and uveitis: A comprehensive review.Surv Ophthalmol. 2022 Mar-Apr;67(2):321-330. doi: 10.1016/j.survophthal.2021.07.006. Epub 2021 Jul 31. Surv Ophthalmol. 2022. PMID: 34343538 Review.
Cited by
-
TRAF molecules in inflammation and inflammatory diseases.Curr Pharmacol Rep. 2018 Feb;4(1):64-90. doi: 10.1007/s40495-017-0117-y. Epub 2017 Dec 20. Curr Pharmacol Rep. 2018. PMID: 29527458 Free PMC article.
-
Advances in the genetically complex autoinflammatory diseases.Semin Immunopathol. 2015 Jul;37(4):403-6. doi: 10.1007/s00281-015-0498-0. Epub 2015 Jun 16. Semin Immunopathol. 2015. PMID: 26077134 Free PMC article. Review.
-
Genetics in Behcet's Disease: An Update Review.Front Ophthalmol (Lausanne). 2022 Jun 3;2:916887. doi: 10.3389/fopht.2022.916887. eCollection 2022. Front Ophthalmol (Lausanne). 2022. PMID: 38983559 Free PMC article. Review.
-
Clinical significance of NCOA5 gene rs2903908 polymorphism in Behçet's disease.EXCLI J. 2017 May 4;16:609-617. doi: 10.17179/excli2017-189. eCollection 2017. EXCLI J. 2017. PMID: 28694762 Free PMC article.
-
Structural feature of TRAFs, their related human diseases and therapeutic intervention.Arch Pharm Res. 2021 May;44(5):475-486. doi: 10.1007/s12272-021-01330-w. Epub 2021 May 10. Arch Pharm Res. 2021. PMID: 33970438 Review.
References
-
- Yang P, Fang W, Meng Q, Ren Y, Xing L, et al. (2008) Clinical features of Chinese patients with Behçet's disease. Ophthalmology 115: 312–318 e314. - PubMed
-
- Yang P, Ren Y, Li B, Fang W, Meng Q, et al. (2007) Clinical characteristics of Vogt–Koyanagi–Harada syndrome in Chinese patients. Ophthalmology 114: 606–614 e603. - PubMed
-
- Zhang Z, Peng J, Hou X, Dong Y (2006) Clinical manifestations of Behcet's disease in Chinese patients. APLAR Journal of Rheumatology 9: 244–247.
-
- Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, et al. (2011) Behcet disease: evolution of clinical manifestations. Medicine (Baltimore) 90: 125–132. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical